on Evotec AG (NASDAQ:EVTCY)
Evotec Announces Change in Management Board
Evotec SE has announced the departure of its Chief Business Officer, Dr. Matthias Evers, effective 01 October 2024. Dr. Evers, who joined Evotec on 01 May 2022, is leaving to pursue new opportunities outside the company. His duties will be distributed across other Management Board functions.
The Chairwoman of Evotec's Supervisory Board, Prof. Dr. Iris Löw-Friedrich, praised Dr. Evers for his significant contributions, including establishing the biologics division Just – Evotec Biologics, and aiding in the recovery from a cyber-attack.
Dr. Christian Wojczewski, CEO of Evotec, also acknowledged Dr. Evers' leadership and commitment, thanking him for his support and expressing confidence in the future success of the company.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Evotec AG news